Parnell (AquaFOL, Pamlin, Ketamine, Methone, KEY and Imidox)
M&A
STATUS
Buyout/LBO
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Manufacturer of veterinary products. The company is engaged in producing medication which are primarily used for starting and maintaining anesthesia among pets in Australia.
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- PO Box 1035
- Mascot, New South Wales 1460
- Australia
Parnell (AquaFOL, Pamlin, Ketamine, Methone, KEY and Imidox) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Parnell (AquaFOL, Pamlin, Ketamine, Methone, KEY and Imidox)‘s full profile, request access.
Request full access to PitchBookParnell (AquaFOL, Pamlin, Ketamine, Methone, KEY and Imidox) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Parnell (AquaFOL, Pamlin, Ketamine, Methone, KEY and Imidox)‘s full profile, request access.
Request full access to PitchBook